Confused about how PEXIVAS reversed MEPEX? Maybe this infographic will help.
Nice work by NSM intern Namrata Parikh.
Background
This week, we will discuss the second part of the 2024 CKD guidelines from KDIGO. Lots to chew on, so let’s dive in!
Background
This week, we will discuss the 2024 KDIGO Guidelines on CKD, part 1. In this section we will discuss the first two chapters on CKD evaluation and risk stratification. Let’s dive in!
Background
This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.
Background
This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
